High expression of EDAG and its significance in AML [8]

Leukemia

Volumn 19, Issue 8, 2005, Pages 1499-1502

  An, L L ^a   Li, G ^a   Wu, K F ^a   Zheng, G G ^a   Qiu, L G ^a   Song, Y H ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; NUCLEAR PROTEIN; RNA; SMALL INTERFERING RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANALYSIS OF VARIANCE; BONE MARROW CELL; CANCER REGRESSION; CD34 SELECTION; CELL DIFFERENTIATION; CELL STRAIN K 562; CONTROLLED STUDY; CYTOCHEMISTRY; DOWN REGULATION; EMBRYONIC DEVELOP ASSOCIATED GENE; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; LETTER; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PRIORITY JOURNAL; RANK SUM TEST; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEQUENCE ANALYSIS;

EID: 23744449590     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403808     Document Type: Letter

References (8)

1. Yang LV, Nicholson RH, Kaplan J, Galy A, Li L. Hemogen is a novel nuclear factor specifically expressed in mouse hematopoietic development and its human homologue EDAG maps to chromosome 9q22, a region containing breakpoints of hematological neoplasms. Mech Dev 2001; 104: 105-111.
2. Li CY, Zhan YQ, Xu CW, Xu WX, Wang SY, Lv J et al. EDAG regulates the proliferation and differentiation of hematopoietic cells and resists cell apoptosis through the activation of nuclear factor-kappaB. Cell Death Differ 2004; 11: 1299-1308.
3. Zhang B, Wang Y, Zheng GG, Ma XT, Li G, Zhang FK et al. Clinical significance of IL-18 gene over-expression in AML. Leukemia Res 2002; 26: 887-892.
4. Yang H, Wang SW, Yin HJ. p21(WAF1) gene transfection inhibits proliferation of leukemia cell line K562. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2001; 9: 115-118.
5. Introna M, Golay J. How can oncogenic transcription factors cause cancer: a critical review of the myb story. Leukemia 1999; 13: 1301-1306.
6. Szczylik C, Skorski T, Malaguarnera L, Hetman J, Chen ST, Calabretta B. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides. Folia Histochem Cytobiol 1996; 34: 129-134.
7. Venditti A, Del Poeta G, Maurillo L, Buccisano F, Del Principe MI, Mazzone C et al. Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemia. Haematologica 2004; 89: 934-939.
8. Gopal V, Hulette B, Li YQ, Kuvelkar R, Raza A, Larson R et al. c-myc and c-myb expression in acute myelogenous leukemia. Leuk Res 1992; 16: 1003-1011.